Anfield Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.5K | Hold |
8,041
| – | – | 0.02% | 145 |
|
|
2025
Q1 | $63.1K | Hold |
8,041
| – | – | 0.02% | 129 |
|
|
2024
Q4 | $120K | Hold |
8,041
| – | – | 0.04% | 86 |
|
|
2024
Q3 | $123K | Hold |
8,041
| – | – | 0.05% | 87 |
|
|
2024
Q2 | $122K | Hold |
8,041
| – | – | 0.06% | 73 |
|
|
2024
Q1 | $152K | Buy |
+8,041
| New | +$152K | 0.07% | 72 |
|
|
2023
Q1 | – | Sell |
-531
| Closed | -$11K | – | 87 |
|
|
2022
Q4 | $11K | Sell |
531
-7,510
| -93% | -$155K | 0.01% | 85 |
|
|
2022
Q3 | $210K | Hold |
8,041
| – | – | 0.1% | 71 |
|
|
2022
Q2 | $204K | Hold |
8,041
| – | – | 0.09% | 73 |
|
|
2022
Q1 | $254K | Hold |
8,041
| – | – | 0.09% | 74 |
|
|
2021
Q4 | $325K | Hold |
8,041
| – | – | 0.11% | 65 |
|
|
2021
Q3 | $275K | Hold |
8,041
| – | – | 0.09% | 76 |
|
|
2021
Q2 | $221K | Hold |
8,041
| – | – | 0.08% | 66 |
|
|
2021
Q1 | $226K | Hold |
8,041
| – | – | 0.09% | 80 |
|
|
2020
Q4 | $209K | Buy |
+8,041
| New | +$209K | 0.09% | 82 |
|
|
2020
Q1 | – | Sell |
-8,041
| Closed | -$76K | – | 312 |
|
|
2019
Q4 | $76K | Buy |
+8,041
| New | +$76K | 0.03% | 190 |
|